Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Streamline Your Pathway To IND With A Rapid Tox Approach
With tox material in hand as soon as possible, antibody-derived drug developers can conduct their tox studies earlier, facilitating a timely IND submission and speeding up pathways to patients.
-
Experimental Pain Models — SNL Model Of Neuropathic Pain
Explore how a validated Spinal Nerve Ligation (SNL) model enables effective preclinical evaluation of novel analgesics for neuropathic pain.
-
Quicker Development Using Cell Line Integration, End-To-End Support
Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
-
Experimental CCI — Induced Neuropathic Pain Model
Advance neuropathic pain research and therapeutic development with the Chronic Constriction Injury (CCI)-induced neuropathic pain model to uncover mechanisms and evaluate promising candidates.
-
Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions
Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Use Of Reconstructed Tissue And 3D Printed Ct-based Nasal Casts For The Assessment Of Nasal Delivery
Reconstructed nasal epithelium and CT-based 3D nasal casts provide more predictive, physiologically relevant models for assessing nasal drug delivery, improving accuracy in formulation development.
-
Improving Consumer Safety Through Innovative Science
Liquid chromatography revolutionizes science with precision. Discover a technology that leads the charge in enhancing HPLC performance for breakthroughs in health, safety, and environmental research.
-
Development Of Separation Methods for GLP-1 Synthetic Peptides
Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.
-
Developing Amorphous Solid Dispersions For Poorly Soluble Drugs
Discover how a strategic amorphous solid dispersion approach improved bioavailability and advanced a low-solubility compound toward clinical readiness in just four weeks.
-
Elevating Purity: Racemizing Pharmaceutical Products In Flow Microreactors
Discover how our process development team resolved a racemization challenge by delivering a biologically active racemic mixture while maintaining compound purity.
FORMULATION DEVELOPMENT SOLUTIONS
- API Stability Combined With Rapid Disintegration
- Single-Use Chromatography System For Advanced Downstream Bioprocessing
- Mass Detection For Undergraduates
- PBPK Predictive Modeling Services
- How Product Quality Translates To Better Results
- Evolve The Future Of Cell Therapy Manufacturing
- Process Liquid Preparation Services
- Small Is Powerful, Small Is Green
- Resin Offering High Productivity And Robust Processes
- Biocatalysis For Cost-Efficient, Environmentally Friendly Manufacturing
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- CDMO BioSpring To Build New API Manufacturing Facility In Germany
- InQuest Science Seeking Business Development Executive To Promote Software Technologies
- Riverarch Equity Partners Announce Acquisition Of Alconox By Portfolio Company TCP Analytical
- CAI And phData Announce Partnership To Accelerate AI-Driven Operational Readiness In Life Sciences
- Sandoz Breaks Announces Construction On New Drug Manufacturing Facility In Slovenia
- CAI And ValGenesis Partner To Deliver AI-Enabled Digital Validation For The Life Sciences Industry
- Hikma Announces $1 Billion Investment For US Drug Manufacturing Facilities
- CDMO Simtra BioPharma Solutions Completes Construction On New Fill/Finish Manufacturing Facility In Germany
- ROSS Introduces A Custom Coaxial Mixer For Complex Formulations
- First Cohort Graduates Biomanufacturing Certification Program At Spokane Colleges